CME Group (NASDAQ:CME) PT Lowered to $178.00
CME Group (NASDAQ:CME) had its price target cut by stock analysts at Deutsche Bank from $196.00 to $178.00 in a report released on Thursday, The Fly reports. The firm currently has a “buy” rating on the financial services provider’s stock. Deutsche Bank’s price objective indicates a potential upside of 7.11% from the stock’s current price.
Several other analysts have also commented on CME. Bank of America dropped their target price on CME Group from $194.00 to $180.00 and set a “neutral” rating on the stock in a report on Friday, July 10th. UBS Group raised their target price on CME Group from $222.00 to $225.00 and gave the stock a “buy” rating in a report on Thursday, April 30th. BidaskClub lowered CME Group from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 14th. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $182.00 target price on the stock in a report on Monday, April 6th. Finally, Goldman Sachs Group lowered their price target on CME Group from $175.00 to $170.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $187.88.
Shares of CME stock traded up $3.08 during mid-day trading on Thursday, reaching $166.18. The stock had a trading volume of 1,845,262 shares, compared to its average volume of 1,553,448. The firm has a market cap of $59.59 billion, a price-to-earnings ratio of 25.06, a PEG ratio of 4.93 and a beta of 0.30. CME Group has a 1-year low of $131.80 and a 1-year high of $225.36. The business’s fifty day moving average is $169.99 and its 200-day moving average is $186.20. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.13.
In related news, Director Timothy S. Bitsberger sold 600 shares of CME Group stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $191.32, for a total transaction of $114,792.00. Following the transaction, the director now owns 9,927 shares in the company, valued at $1,899,233.64. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director William R. Shepard acquired 771 shares of CME Group stock in a transaction that occurred on Tuesday, June 2nd. The shares were bought at an average price of $178.10 per share, for a total transaction of $137,315.10. Following the transaction, the director now owns 771 shares of the company’s stock, valued at approximately $137,315.10. The disclosure for this purchase can be found here. Company insiders own 1.20% of the company’s stock.
A number of institutional investors have recently made changes to their positions in CME. Tarbox Family Office Inc. lifted its holdings in CME Group by 55.6% in the first quarter. Tarbox Family Office Inc. now owns 168 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 60 shares during the last quarter. Private Vista LLC boosted its stake in CME Group by 2.3% in the 2nd quarter. Private Vista LLC now owns 2,834 shares of the financial services provider’s stock worth $461,000 after purchasing an additional 65 shares during the period. Magnolia Capital Advisors LLC boosted its stake in CME Group by 3.3% in the 2nd quarter. Magnolia Capital Advisors LLC now owns 2,091 shares of the financial services provider’s stock worth $340,000 after purchasing an additional 66 shares during the period. Verus Capital Partners LLC boosted its stake in CME Group by 0.9% in the 1st quarter. Verus Capital Partners LLC now owns 7,245 shares of the financial services provider’s stock worth $1,253,000 after purchasing an additional 67 shares during the period. Finally, Buckley Wealth Management LLC boosted its stake in CME Group by 4.0% in the 2nd quarter. Buckley Wealth Management LLC now owns 1,789 shares of the financial services provider’s stock worth $291,000 after purchasing an additional 68 shares during the period. Hedge funds and other institutional investors own 84.83% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: What is diluted earnings per share (Diluted EPS)?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.